Acrivon Therapeutics, Inc. Common Stock
ACRV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $39,818 | $36,015 | $29,519 | $99,603 |
| Short-Term Investments | $139,662 | $91,443 | $98,232 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2,149 | $2,234 | $4,344 | $805 |
| Total Curr. Assets | $181,629 | $129,692 | $132,095 | $100,408 |
| Property Plant & Equip (Net) | $8,025 | $7,908 | $6,862 | $5,791 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $5,089 | $0 | $41,881 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1,845 | $665 | $388 | $388 |
| Total NC Assets | $14,959 | $8,573 | $49,131 | $6,179 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $196,588 | $138,265 | $181,226 | $106,587 |
| Liabilities | – | – | – | – |
| Payables | $758 | $5,048 | $904 | $964 |
| Short-Term Debt | $1,057 | $877 | $726 | $664 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $69 | $66 |
| Other Curr. Liab. | $15,399 | $7,378 | $4,817 | $1,220 |
| Total Curr. Liab. | $17,214 | $13,303 | $6,516 | $2,914 |
| LT Debt | $2,588 | $3,767 | $4,235 | $4,964 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $122,518 |
| Total NC Liab. | $2,588 | $3,767 | $4,235 | $127,482 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2,588 | $4,644 | $4,961 | $5,628 |
| Total Liabilities | $19,802 | $17,070 | $10,751 | $130,396 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $31 | $23 | $22 | $2 |
| Retained Earnings | -$196,976 | -$116,420 | -$56,032 | -$24,865 |
| AOCI | $447 | -$83 | -$95 | $0 |
| Other Equity | $373,284 | $237,675 | $226,580 | $1,054 |
| Total Equity | $176,786 | $121,195 | $170,475 | -$23,809 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $196,588 | $138,265 | $181,226 | $106,587 |
| Net Debt | -$36,173 | -$31,371 | -$24,558 | -$93,975 |